CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
Christoph Wohlmuth(Memorial Hermann), Taymaa May(University Health Network), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Sharon E. Johnatty(QIMR Berghofer Medical Research Institute), Claus Høgdall(Copenhagen University Hospital), Line Bjørge(Haukeland University Hospital), Anna DeFazio(The University of Sydney), Liv Cecilie Vestrheim Thomsen(Haukeland University Hospital), Vladimir Djedovic(University Health Network), Stacey J. Winham(Mayo Clinic), Marjorie J. Riggan(Duke Medical Center), Estrid Høgdall(University of Copenhagen), Susanne K. Kjær(Copenhagen University Hospital), Marc T. Goodman(Cedars-Sinai Medical Center), Andrew Berchuck(General Marble (Greece)), Rosalind Glasspool(Institut Bergonié), Patricia Roxburgh(Beatson West of Scotland Cancer Centre), Alicia Tone(BC Cancer Agency), Joellen M. Schildkraut(Duke University Hospital), Keitaro Matsuo(Aichi Cancer Center), Tanja Pejović(Oregon Health & Science University), Katherine Lajkosz(University Health Network), Francesmary Modugno(University of Pittsburgh), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Beth Y. Karlan(University of California, Los Angeles), Jenny Lester(Cedars-Sinai Medical Center), Allan Jensen(Danish Cancer Society), Pamela J. Thompson(Cancer Prevention Institute of California), Ellen L. Goode(Mayo Clinic in Arizona)
Cited by 13
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k